Stocks and Investing Stocks and Investing
Thu, August 8, 2019
Wed, August 7, 2019
Tue, August 6, 2019

Ed Arce Maintained (AKBA) at Strong Buy with Decreased Target to $17 on, Aug 6th, 2019


Published on 2024-10-26 15:24:09 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $19 to $17 on, Aug 6th, 2019.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Eric Joseph of "JP Morgan" Initiated at Buy on, Thursday, May 2nd, 2019
Contributing Sources